Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Stephen, Shumack"'
Autor:
Lynda Spelman, Andrew E. Potter, Chris Baker, Stephen Shumack, Robert Sinclair, David Christie, Bradley Wong, Peter Foley, Steven Hacker, Cody C. Allison, the National Dermatology Radiation Oncology Registry (NDROR) investigators and sites
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 487-497 (2024)
Abstract Background Widefield radiation therapy (RT) has emerged as a treatment option for extensive skin field cancerization (ESFC), with or without keratinocyte cancer (KC). Objectives To assess the long‐term efficacy, safety, cosmesis and qualit
Externí odkaz:
https://doaj.org/article/1fcca7d2552f4cb7ae75c3cd0c583613
Autor:
Marjolein de Bruin-Weller, Mette Deleuran, Tilo Biedermann, Robert Bissonnette, Peter Foley, Giampiero Girolomoni, Jana Hercogová, Chih-Ho Hong, Norito Katoh, Andrew Pink, Marie-Aleth Richard, Stephen Shumack, Juan Francisco Silvestre, Jacob P. Thyssen, Stephan Weidinger
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
Atopic dermatitis is a chronic skin condition for which a range of systemic treatments have recently been approved. A treat-to-target strategy has been developed previously alongside an algorithm to guide the management of patients with atopic dermat
Externí odkaz:
https://doaj.org/article/4f64746c251d43be8b51d8e068e15cc2
Autor:
Yandong Shen, Luke Coyle, Ian Kerridge, William Stevenson, Christopher Arthur, Naomi McKinlay, Keith Fay, Christopher Ward, Matthew Greenwood, Oliver Giles Best, Ann Solterbeck, Alexander Guminski, Stephen Shumack, Stephen P. Mulligan
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 129-138 (2022)
Abstract Chronic lymphocytic leukaemia (CLL) is invariably accompanied by some degree of immune failure, and CLL patients have a high rate of second primary malignancy (SPM) compared to the general population. We comprehensively documented the incide
Externí odkaz:
https://doaj.org/article/bfe51b01464c452490529972a47017e0
Publikováno v:
Pigment International, Vol 9, Iss 2, Pp 127-130 (2022)
Background: Vitiligo is an autoimmune skin disorder characterized by patches of depigmentation due to loss of melanocytes. Vitiligo is associated with significant psychosocial burden, with prior studies showing links with psychiatric comorbidities su
Externí odkaz:
https://doaj.org/article/dd18c998539b4d3db253683f25e325d4
Autor:
Marjolein De Bruin-Weller, Tilo Biedermann, Robert Bissonnette, Mette Deleuran, Peter Foley, Giampiero Girolomoni, Jana Hercogová, Chih-Ho Hong, Norito Katoh, Andrew E. Pink, Marie-Aleth Richard, Stephen Shumack, Juan F. Silvestre, Stephan Weidinger
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 2, p adv00402 (2021)
Currently no treat-to-target framework to guide systemic treatment in adults with moderate-to-severe atopic dermatitis exists. We sought to reach international consensus through an eDelphi process on a core set of recommendations for such an approach
Externí odkaz:
https://doaj.org/article/c946a16099f342538febe70c6a2106da
Publikováno v:
Australasian Journal of Dermatology. 64:291-295
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::270dd809c261edd077732b39db7e77ee
https://doi.org/10.1111/ajd.13994
https://doi.org/10.1111/ajd.13994
Autor:
Stephen K. Tyring, Phoebe Rich, Yayoi Tada, Stefan Beeck, Izabella Messina, Jie Liu, Xiaohong Huang, Stephen Shumack
Publikováno v:
Dermatology and Therapy. 13:595-608
Atopic dermatitis (AD) is a heterogeneous disease, with involvement of the T-helper cell (Th) 2, Th22, and potentially Th17 pathways, supporting the use of interleukin (IL)-23 and IL-22 blockade in AD.This phase 2, multicenter, randomized, double-bli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5512666d04a73d2a9a852699ba85221e
https://doi.org/10.1007/s13555-022-00876-x
https://doi.org/10.1007/s13555-022-00876-x
Autor:
Vivian Y, Shi, Tina, Bhutani, Luz, Fonacier, Mette, Deleuran, Stephen, Shumack, Hernan, Valdez, Fan, Zhang, Gary L, Chan, Michael C, Cameron, Natalie C, Yin
Publikováno v:
Shi, V Y, Bhutani, T, Fonacier, L, Deleuran, M, Shumack, S, Valdez, H, Zhang, F, Chan, G L, Cameron, M C & Yin, N C 2022, ' Phase 3 Efficacy and Safety of Abrocitinib in Adults with Moderate-to-Severe Atopic Dermatitis After Switching from Dupilumab (JADE EXTEND) ', Journal of the American Academy of Dermatology, vol. 87, no. 2, pp. 351-358 . https://doi.org/10.1016/j.jaad.2022.04.009
BACKGROUND: Abrocitinib efficacy by prior dupilumab response status in patients with moderate-to-severe atopic dermatitis (AD) has not previously been assessed in phase 3 studies.OBJECTIVE: Examine efficacy and safety of abrocitinib among patients wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a7a61a7bb21623cbeb8dbaf42cf563
https://doi.org/10.1016/j.jaad.2022.04.009
https://doi.org/10.1016/j.jaad.2022.04.009
Autor:
Christopher Baker, Amelia James, Madeleine Supranowicz, Lynda Spelman, Stephen Shumack, Judith Cole, Warren Weightman, Robert Sinclair, Peter Foley
Publikováno v:
Clinical and Experimental Dermatology. 47:1144-1153
Summary Background A range of ‘field-directed’ treatments is available for the management of extensive skin field cancerization (ESFC), but to date, the only validated objective quantitative tools are limited to assessment of actinic keratoses (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc8cb5f821e87f8444adb4aa81b5f330
https://doi.org/10.1111/ced.15136
https://doi.org/10.1111/ced.15136
Publikováno v:
International Journal of Radiology & Radiation Therapy. 8:144-154
Introduction: The Australian 2002 National Health and Medical Research Council (NHMRC) treatment guidelines for non-melanoma skin cancer (NMSC) were updated in 2008. At this time, the lack of high-quality Australian research conducted between 2002 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::192af9b192ddb96c5dff9da7994c1479
https://doi.org/10.15406/ijrrt.2021.08.00307
https://doi.org/10.15406/ijrrt.2021.08.00307